Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
Guidelines for treatment of drug-susceptible tuberculosis and patient care
Update 2017
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
180
Biomédica 2018;38:180-8
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
4th edition. This is fourth edition of Treatment of tuberculosis: guidelines, adhering fully to the new WHO process for evidence-based guidelines. Several important recommendations are being promoted in this new edition
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10